Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Rapa

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pathologica|January 31, 2006
[Immunohistochemistry in thyroid needle aspiration samples]M Papotti, A Fornari, I Rapa, et al.
Targeted Oncology|August 29, 2015
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective StudyS Vatrano, L Righi, T Vavalá, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineP Ceppi, M Volante, S Novello, et al.
ESMO Open|September 15, 2023
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across EuropeP Hofman, F Calabrese, I Kern, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pathologica|January 31, 2006
[Immunohistochemistry in thyroid needle aspiration samples]M Papotti, A Fornari, I Rapa, et al.
Targeted Oncology|August 29, 2015
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective StudyS Vatrano, L Righi, T Vavalá, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineP Ceppi, M Volante, S Novello, et al.
ESMO Open|September 15, 2023
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across EuropeP Hofman, F Calabrese, I Kern, et al.
Pageof 1